MedPath

Effect of dexamethasone on the goiterous size

Not Applicable
Conditions
Goiterous Hashimoto's thyroiditis with subclinical Hyothyroidism.
Registration Number
IRCT201103023565N3
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

goiterous Hashimoto's thyroiditis with subclinical hypothyroidism, TSH = 10 mIU/L, AntiTPO + or AntiTG
Exclusion criteria: Age between 15 and more than70, Use of corticosteroids therapy dose in the past six months for any reason, Use of antithyroid drugs at the baseline, Psychotic and psycho somatic diseases, Atrophic form of goiterous Hashimoto's thyroiditis, no consent to participate in the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(TSH) Thyroid Stimulating Hormone. Timepoint: Baseline, the end of the third month and sixth month end. Method of measurement: Laboratory.
Secondary Outcome Measures
NameTimeMethod
Antibody Against Thyroid Peroxidase (Anti TPO). Timepoint: Baseline, the end of the third month and sixth month end. Method of measurement: Laboratory.;Goiterous size. Timepoint: Baseline, the end of the third month and sixth month end. Method of measurement: Radiology.
© Copyright 2025. All Rights Reserved by MedPath